TY - JOUR
T1 - Clinical Breast Cancer Registry of IR. Iran (CBCR-IR)
T2 - Study Protocol and First Results
AU - Seyyedsalehi, Monireh Sadat
AU - Nahvijou, Azin
AU - Haghjooy Javanmard, Shaghayegh
AU - Vand Rajabpour, Mojtaba
AU - Manteghinejad, Amirreza
AU - Pirnejad, Habibollah
AU - Niazkhani, Zahra
AU - Golpazir Sorkheh, Arash
AU - Baniamer, Maryam
AU - Anasari, Jamshid
AU - Bahrami, Masoud
AU - Marzban, Maryam
AU - Esfandiari, Atefeh
AU - Ghoreishi, Seyedeh Masoumeh
AU - Nikbakhsh, Novin
AU - Baharvand Iran Nia, Yahya
AU - Ahmadi Somaghian, Shahram
AU - Ashoobi, Mohammad Taghi
AU - Bakhshi, Fataneh
AU - Ansari-Moghaddam, Alireza
AU - Bakhshi, Mahdieh
AU - Moradi Binabaj, Maryam
AU - Nourmohammadi, Hassan
AU - Omranipour, Ramesh
AU - Zendehdel, Kazem
N1 - © 2023 The Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
PY - 2023/11/1
Y1 - 2023/11/1
N2 - BACKGROUND: Breast cancer (BC), as a significant global health problem, is the most common cancer in women. Despite the importance of clinical cancer registries in improving the quality of cancer care and cancer research, there are few reports on them from low- and middle-income countries. We established a multicenter clinical breast cancer registry in Iran (CBCR-IR) to collect data on BC cases, the pattern of care, and the quality-of-care indicators in different hospitals across the country.METHODS: We established a clinical cancer registry in 12 provinces of Iran. We defined the organizational structure, developed minimal data sets and data dictionaries, verified data sources and registration processes, and developed the necessary registry software. During this registry, we studied the clinical characteristics and outcomes of patients with cancer who were admitted from 2014 onwards.RESULTS: We registered 13086 BC cases (7874 eligible cases) between 1.1.2014 and 1.1.2022. Core needle biopsy from the tumor (61.25%) and diagnostic mammography (68.78%) were the two most commonly used diagnostic methods. Stage distribution was 2.03% carcinoma in situ, 12% stage I, 44.65% stage II, 21.32% stage III, and 4.61% stage IV; stage information was missing in 1532 patients (19.46%). Surgery (95.01%) and chemotherapy (79.65%) were the most common treatments for all patients.CONCLUSION: The information provided by this registry can be used to evaluate and improve the quality of care for BC patients. It will be scaled up to the national level as an important resource for measuring quality of care and conducting clinical cancer research in Iran.
AB - BACKGROUND: Breast cancer (BC), as a significant global health problem, is the most common cancer in women. Despite the importance of clinical cancer registries in improving the quality of cancer care and cancer research, there are few reports on them from low- and middle-income countries. We established a multicenter clinical breast cancer registry in Iran (CBCR-IR) to collect data on BC cases, the pattern of care, and the quality-of-care indicators in different hospitals across the country.METHODS: We established a clinical cancer registry in 12 provinces of Iran. We defined the organizational structure, developed minimal data sets and data dictionaries, verified data sources and registration processes, and developed the necessary registry software. During this registry, we studied the clinical characteristics and outcomes of patients with cancer who were admitted from 2014 onwards.RESULTS: We registered 13086 BC cases (7874 eligible cases) between 1.1.2014 and 1.1.2022. Core needle biopsy from the tumor (61.25%) and diagnostic mammography (68.78%) were the two most commonly used diagnostic methods. Stage distribution was 2.03% carcinoma in situ, 12% stage I, 44.65% stage II, 21.32% stage III, and 4.61% stage IV; stage information was missing in 1532 patients (19.46%). Surgery (95.01%) and chemotherapy (79.65%) were the most common treatments for all patients.CONCLUSION: The information provided by this registry can be used to evaluate and improve the quality of care for BC patients. It will be scaled up to the national level as an important resource for measuring quality of care and conducting clinical cancer research in Iran.
UR - http://www.scopus.com/inward/record.url?scp=85184098805&partnerID=8YFLogxK
U2 - 10.34172/aim.2023.90
DO - 10.34172/aim.2023.90
M3 - Article
C2 - 38310420
SN - 1029-2977
VL - 26
SP - 607
EP - 617
JO - Archives of Iranian Medicine
JF - Archives of Iranian Medicine
IS - 11
ER -
